Screener
Innovative Industrial Properties, Inc. IIPR Life Science Portfolio Segment: — Net Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Innovative Industrial Properties, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Innovative Industrial Properties, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001677576-26-000002
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Cannabis Portfolio Segment net income | 43,700 | 43,025 |
| Life Science Portfolio Segment: | ||
| Interest and other income | 5,544 | — |
| Life Science Portfolio Segment net income | 5,544 | — |
| Total reportable segment net income | 49,244 | 43,025 |
| Unallocated: | ||
| General and administrative expense | (10,349) | (8,461) |
| Interest and other income | 345 | 1,013 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Innovative Industrial Properties, Inc.'s life science portfolio segment: — net income?
- Innovative Industrial Properties, Inc. (IIPR) reported life science portfolio segment: — net income of $5.54M in Q1 2026.
- What does life science portfolio segment: — net income mean?
- This metric measures the total profitability of the life science portfolio segment after accounting for all associated operating expenses, depreciation, and interest costs. It reflects the bottom-line financial performance of this specific asset class within the broader corporate structure. Investors use this to evaluate the segment's contribution to overall company earnings and its operational efficiency.
Ask your AI about Innovative Industrial Properties, Inc.'s life science portfolio segment: — net income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude